| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents.
|
Bioorg Med Chem
|
2011
|
0.93
|
|
2
|
Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
|
Bioorg Med Chem
|
2011
|
0.89
|
|
3
|
Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents.
|
Bioorg Med Chem
|
2013
|
0.87
|
|
4
|
Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
|
Eur J Med Chem
|
2012
|
0.86
|
|
5
|
Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents.
|
Bioorg Med Chem Lett
|
2011
|
0.83
|
|
6
|
Advances in the researches on the biological activities and inhibitors of phosphatidylinositol 3-kinase.
|
Anticancer Agents Med Chem
|
2014
|
0.80
|
|
7
|
Design, modification and 3D QSAR studies of novel 2,3-dihydrobenzo[b][1,4]dioxin-containing 4,5-dihydro-1H-pyrazole derivatives as inhibitors of B-Raf kinase.
|
Bioorg Med Chem
|
2012
|
0.78
|
|
8
|
Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
|
Bioorg Med Chem Lett
|
2012
|
0.77
|
|
9
|
Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
|
Bioorg Med Chem
|
2011
|
0.76
|
|
10
|
Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
|
Bioorg Med Chem
|
2012
|
0.75
|